skip to Main Content

Let’s Win Announces Let’s Learn Webinar Series

webinar announcement
Let’s Win is hosting Let’s Learn, a series of webinars for health care professionals.

The webinars will share the latest information about risk factors, symptoms, and treatment options for pancreatic cancer. Each webinar will be one hour in length and will be held at 7 pm ET. They will be moderated by BRCA advocate Erika Stallings and will feature a panel of experts on pancreatic cancer.

About 57,000 people are diagnosed with pancreatic cancer each year in the U.S., and the rate of occurrence is slightly higher in Blacks than any other group.  The five-year survival rate for pancreatic cancer is about 10%, in part because the disease is often diagnosed at an advanced stage. This is because tumors are not found on a physical exam and the symptoms mimic many other more common conditions.

By learning more about the risk factors and recognizing the group of symptoms, health care professionals can increase a patient’s chance of an earlier diagnosis, which leads to more treatment options and a better survival rate.

The first webinar, Learn the Risk Factors, will be held on February 25th. Expert panelists, including include Dr. Suresh Chari and Dr. Anirban Maitra, will discuss how lifestyle, health issues, and genetics increase a person’s risk of developing pancreatic cancer.

The second webinar, Recognize Symptoms, is scheduled for March 25th. The discussion will focus on common symptoms of pancreatic cancer, and how this combination of symptoms can be a warning sign of pancreatic cancer rather than something else. For high-risk people, this information is particularly important.

The final webinar in the series, Find Treatment Options, on April 29th, will discuss the latest treatment options, the importance of genetic testing and molecular profiling, and why clinical trials are so important for pancreatic cancer patients.

The information in these webinars can help you learn to recognize who is at risk of developing pancreatic cancer, when a patient needs further testing, and the best treatment options.

Register here to join the first webinar.


Back To Top